Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RU 24969

Known as: RU-24969 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Male Sprague-Dawley rats deprived of food for 18 h were injected with the 5-HT agonists RU 24969, 1-(3-chlorophenyl)piperazine… Expand
  • table 1
  • table 2
  • table 4
  • table 5
  • table 6
Highly Cited
1999
Highly Cited
1999
Augmentation of tricyclic antidepressant (TCA) treatment with triiodothyronine (T3) has been shown to potentiate the therapeutic… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Highly Cited
1993
Highly Cited
1993
When animals are exposed to a stimulus that has no consequences they are subsequently impaired in learning that this stimulus… Expand
  • table 1
  • figure 2
  • figure 3
Highly Cited
1991
Highly Cited
1991
We have compared the ability of the new putatively specific 5-HT1B receptor agonist CP-93,129 (3-(1,2,5,6-tetrahydropyrid-4-yl… Expand
Highly Cited
1986
Highly Cited
1986
The interaction of RU 24969 with [3H]5-hydroxytryptamine ([3H]5-HT) binding to non-5-HT1A binding sites was analyzed in nine… Expand
Highly Cited
1986
Highly Cited
1986
The roles of recognition sites for central neurotransmitters in the mediation of the behavioural effects of the putative 5… Expand
Highly Cited
1986
Highly Cited
1986
  • S. Peroutka
  • Journal of neurochemistry
  • 1986
  • Corpus ID: 25108290
Abstract: Drug interactions with 5‐HT1 (5‐hydroxytryptamine type 1) binding site subtypes were analyzed in rat frontal cortex. 8… Expand
Highly Cited
1985
Highly Cited
1985
1 Radioligand binding techniques have demonstrated the existence of 5‐hydroxytryptamine (5‐HT) binding subtypes: 5‐HT2, 5‐HT1A… Expand
Highly Cited
1984
Highly Cited
1984
Some behavioural and biochemical consequences of the administration of RU 24969 (5-methoxy-3(1,2,3,6-tetrahydropyridin-4-yl)-1H… Expand
Highly Cited
1980
Highly Cited
1980
The most potent compound of a series of piperidinyl indole derivatives which decrease 5-hydroxyindole acetic acid (5-HIAA) levels… Expand